Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances
Year: 2022
Type: review
Abstract: Due to complicated anatomical and physical properties, targeted drug delivery to ocular tissues continues to be a key challenge for formulation scientists. Various attempts are currently being made to improve the in vivo performance of therapeutic molecules by encapsulating them in various nanocarrier systems or devices and administering them via invasive/non-invasive or minimally invasive drug administration methods. Biocompatible and biodegradable lipid nanoparticles have emerged as a potential alternative to conventional ocular drug delivery systems to overcome various ocular barriers. Lipid-based nanocarrier systems led to major technological advancements and therapeutic advantages during the last few decades of ocular therapy, such as high precorneal residence time, sustained drug release profile, minimum dosing frequency, decreased drug toxicity, targeted site delivery, and, therefore, an improvement in ocular bioavailability. In addition, such formulations can be given as fine dispersion in patient-friendly droppable preparation without causing blurred vision and ocular sensitivity reactions. The unique advantages of lipid nanoparticles, namely, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, and liposomes in intraocular targeted administration of various therapeutic drugs are extensively discussed. Ongoing and completed clinical trials of various liposome-based formulations and various characterization techniques designed for nanoemulsion in ocular delivery are tabulated. This review also describes diverse solid lipid nanoparticle preparation methods, procedures, advantages, and limitations. Functionalization approaches to overcome the drawbacks of lipid nanoparticles, as well as the exploration of new functional additives with the potential to improve the penetration of macromolecular pharmaceuticals, would quickly progress the challenging field of ocular drug delivery systems.
Source: Pharmaceutics
Authors: Shery Jacob(Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing), Anroop B. Nair(Conceptualization, Data curation, Formal analysis, Writing – review & editing), Jigar Shah(Conceptualization, Data curation, Formal analysis, Writing – review & editing), Sumeet Gupta(Data curation, Formal analysis, Writing – original draft), Sai H. S. Boddu(Data curation, Formal analysis, Writing – original draft), Nagaraja Sreeharsha(Data curation, Formal analysis, Writing – original draft), Alex Joseph(Data curation, Writing – original draft), Pottathil Shinu(Data curation, Writing – original draft), Mohamed A. Morsy(Data curation, Writing – original draft)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,513
Funder: Gulf Medical University
OpenAlex ID: W4214619575
